Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Top 10 Trends to Watch in Ophthalmology
The field of ophthalmology is constantly evolving with new technologies and treatments emerging every year. In the next decade, we can expect even more advancements that will revolutionize the way we approach eye care. Here are the top 10 eye…
Ophthalmology’s Leap with Emerging Technologies
In a recent survey conducted on LinkedIn by the Ophthalmology Breaking News (OBN), ophthalmology professionals were asked to identify the emerging technology they believed held the most promise for improving surgical outcomes in their field. The results shed light on…
Best 6 Advances in Cataract Surgery
Cataract surgery has undergone remarkable advancements, leading to significant improvements in patient outcomes and revolutionizing the field of ophthalmology. From advanced surgical techniques to innovative intraocular lens (IOL) options, this article explores the top six breakthroughs in cataract surgery that…
10 Facts About Ophthalmologists and Their Work
Ophthalmologists, often referred to as eye doctors, are healthcare professionals who specialize in the diagnosis, treatment, and management of eye diseases and disorders. While we may visit them for routine eye exams or specific vision concerns, the world of ophthalmology…
New FDA Warning: Hearing Impairment Risks in TEPEZZA
The US Food and Drug Administration (FDA) has taken action to update the warning label on Horizon Pharmaceutical’s TEPEZZA, a drug used to treat thyroid eye disease (TED), to include the risk of hearing impairment or loss. The recent addition…
FDA Accepts Application for Genentech’s Vabysmo for RVO
Genentech announced that the FDA has accepted the company’s supplemental biologics license application (sBLA) for Vabysmo (faricimab-svoa) for the treatment of macular edema following retinal vein occlusion (RVO). The sBLA is based on data from the phase 3 BALATON and…
Alimera Wraps Synchronicity Study Enrollment for Yutiq in Uveitis
Alimera Sciences has reached its enrollment target for the Synchronicity study, marking a significant milestone in the prospective, open-label clinical investigation of Yutiq (fluocinolone acetonide intravitreal implant 0.18mg). The study focuses on assessing the safety and efficacy of Yutiq in…
Harrow Secures US and Canadian Rights to Vevye
Harrow has recently announced a significant development by entering the prescription dry eye disease treatment market. The company has successfully struck a deal to acquire the commercial rights for Vevye (cyclosporine ophthalmic solution 0.1%) in both the United States and…
2023 Recap: Top 15 Firsts in Ophthalmology
In a year marked by groundbreaking achievements, the field of ophthalmology witnessed a series of historic firsts, pushing the boundaries of innovation and patient care. Here are the noteworthy milestones: Pioneering the integration of technology into glaucoma management, the world’s…
Patient Compliance: A Major Challenge for Ophthalmologists
According to the results of a recent LinkedIn survey conducted by our team, treating eye conditions can be a daunting task for medical professionals due to several challenges. Patient Compliance The survey asked attendees what their biggest challenge was when…